Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades

被引:20
作者
Gargate, Maria Joao [1 ]
Ferreira, Idalina [1 ]
Vilares, Anabela [1 ]
Martins, Susana [1 ]
Cardoso, Carlos [2 ]
Silva, Susana [3 ]
Nunes, Baltazar [3 ]
Gomes, Joao Paulo [4 ]
机构
[1] Natl Inst Hlth, Natl Reference Lab Parasit & Fungal Infect, Lisbon, Portugal
[2] Clin Lab Dr Joaquim Chaves, Lisbon, Portugal
[3] Natl Inst Hlth, Dept Epidemiol, Lisbon, Portugal
[4] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal
来源
BMJ OPEN | 2016年 / 6卷 / 10期
关键词
PREGNANT-WOMEN; INFECTION; PREVALENCE; AGE;
D O I
10.1136/bmjopen-2016-011648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Toxoplasma gondii is an obligate intracellular protozoan infecting up to one-third of the world's population, constituting a life threat if transmitted from mother to child during pregnancy. In Portugal, there is a lack of knowledge of the current epidemiological situation, as the unique toxoplasmosis National Serological Survey was performed in 1979/1980. Methods: We studied the seroprevalence trends in the Portuguese general population over the past 3 decades, by assessing chronological spread cross-sectional studies, with special focus on women of childbearing age, by age group, region and gender. Results: The T. gondii overall seroprevalence decreased from 47% in 1979/1980 to 22% (95% CI 20% to 24%) in 2013. Generally, we observed that the prevalence of T. gondii IgG increased significantly with age and it decreased over time, both in the general population and in the childbearing women (18% prevalence in 2013). Conclusions: The scenario observed for the latter indicates that more than 80% of childbearing women are susceptible to primary infection yielding a risk of congenital toxoplasmosis and respective sequelae. Since there is no vaccine to prevent human toxoplasmosis, the improvement of primary prevention constitutes a major tool to avoid infection in such susceptible groups.
引用
收藏
页数:7
相关论文
共 32 条
[1]   Prevalence and incidence in Albacete, Spain, of Toxoplasma gondii infection in women of childbearing age.: Differences between immigrant and non-immigrant (2001-2007) [J].
Alvarez, Joaquin-Bartolome ;
Serrano, Maria Martinez ;
Parrado, Laura Moreno ;
Ortuno, Santiago Lorente ;
Sanchez, Maria Dolores Crespo .
REVISTA ESPANOLA DE SALUD PUBLICA, 2008, 82 (03) :333-342
[2]  
Angelo M.H., 1983, Arq. Inst. Nac. Saude, V8, P105
[3]  
Angelo M. H., 2003, ARCH PEDIATR, V10, P25
[4]  
[Anonymous], 2007, EFSAJ, V83, P1
[5]   Kinetics of Toxoplasma infection in the Balkans [J].
Bobic, Branko ;
Nikolic, Aleksandra ;
Klun, Ivana ;
Djurkovic-Djakovic, Olgica .
WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 :2-6
[6]   Sources of toxoplasma infection in pregnant women: European multicentre case-control study [J].
Cook, AJC ;
Gilbert, RE ;
Buffolano, W ;
Zufferey, J ;
Petersen, E ;
Jenum, PA ;
Foulon, W ;
Semprini, AE ;
Dunn, DT .
BRITISH MEDICAL JOURNAL, 2000, 321 (7254) :142-147
[7]   Cats and Toxoplasma: Implications for Public Health [J].
Dabritz, H. A. ;
Conrad, P. A. .
ZOONOSES AND PUBLIC HEALTH, 2010, 57 (01) :34-52
[8]   Seroepidemiological Surveys of Non Vaccine-Preventable Diseases and their Interest in PublicHealth [J].
de Ory Manchon, Fernando .
REVISTA ESPANOLA DE SALUD PUBLICA, 2009, 83 (05) :645-657
[9]   Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years [J].
Diza, E ;
Frantzidou, F ;
Souliou, E ;
Arvanitidou, M ;
Gioula, G ;
Antoniadis, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (09) :719-723
[10]  
European Center of Disease Prevention and Control, 2013, ANN EP REP 2013 REP, DOI DOI 10.2900/13174